Mark Assmus

ORCID: 0000-0003-3615-9251
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Kidney Stones and Urolithiasis Treatments
  • Urological Disorders and Treatments
  • Pediatric Urology and Nephrology Studies
  • Pelvic floor disorders treatments
  • Bladder and Urothelial Cancer Treatments
  • Ureteral procedures and complications
  • Hormonal and reproductive studies
  • Urinary Tract Infections Management
  • Opioid Use Disorder Treatment
  • Colorectal Cancer Screening and Detection
  • Renal and Vascular Pathologies
  • Urinary and Genital Oncology Studies
  • Renal cell carcinoma treatment
  • Sexual function and dysfunction studies
  • Connexins and lens biology
  • Pain Management and Opioid Use
  • Digital Imaging in Medicine
  • Prostate Cancer Treatment and Research
  • Anesthesia and Pain Management
  • Abdominal Surgery and Complications
  • Anatomy and Medical Technology
  • Urologic and reproductive health conditions
  • Male Reproductive Health Studies

University of Calgary
2022-2025

Northwestern University
2021-2023

University of Alberta
2013-2022

Indiana University – Purdue University Indianapolis
2020-2022

Indiana University School of Medicine
2020-2021

Methodist Hospital
2021

Houston Methodist
2021

University of Victoria
2013

Weatherford College
2000

Objective To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper urothelial [UTUC] and renal cancer) in patients referred to secondary care with haematuria, adjusted for established patient risk markers geographical variation. Patients Methods This was an international multicentre prospective observational study. We included aged ≥16 years, suspected cancer. a known or previous urological malignancy were excluded. estimated bladder UTUC, prostate cancer;...

10.1111/bju.15483 article EN cc-by-nc BJU International 2021-05-15

Background: Holmium laser enucleation of the prostate (HoLEP) is a highly effective and durable minimally invasive surgery for benign prostatic hyperplasia. Historically, alternative treatments large glands (≥175 cc) are associated with prolonged length stay (LOS) postoperative catheterization. However, advances in technology combined surgical technique optimization have early evidence supporting same-day discharge. We look to examine contemporary discharge outcomes glands. Materials...

10.1089/end.2020.1218 article EN Journal of Endourology 2021-02-11
Sinan Khadhouri Kevin Gallagher Kenneth R. MacKenzie Taimur T. Shah Chuanyu Gao and 95 more Sacha Moore Eleanor Zimmermann Eric Edison Matthew Jefferies Arjun Nambiar Thineskrishna Anbarasan Miles Mannas Taeweon Lee Giancarlo Marra Juan Gómez Rivas Gautier Marcq Mark Assmus Taha Uçar Francesco Claps M. Boltri Giuseppe La Montagna Tara Burnhope Nkwam Nkwam Tomas Austin Nicholas E. Boxall Alison Downey Troy A. Sukhu M. Antón-Juanilla Sonpreet Rai Yew-Fung Chin Madeline Moore Tamsin Drake James Green Beatriz Goulão Graeme MacLennan Matthew E. Nielsen John McGrath Veeru Kasivisvanathan Aasem Chaudry A. S. Sharma Adam Bennett Adnan Ahmad Ahmed Abroaf Ahmed Musa Suliman Aimee Lloyd Alastair McKay Albert J. Wong José Alberto Silva Alexandre Schneider Alison MacKay Allen Knight Alkiviadis Grigorakis Amar Bdesha Amy Nagle Ana Cebola Ananda Kumar Dhanasekaran Andraž Kondža André Silva Andrea Benedetto Galosi Andrea Ebur Andrea Minervini Andrew Russell Andrew Webb Ángel García de Jalón Ankit A. Desai Anna Czech Anna Mainwaring Anthony Adimonye Arighno Das Arnaldo Figueiredo Arnauld Villers Artur Lemiński Arvinda Chippagiri Asim Ahmed Lal Asıf Yıldırım Athanasios Marios Voulgaris Audrey Uzan Aye Moh Moh Oo Ayman Younis Bachar Zelhof Bashir Mukhtar Benjamin Ayres Ben Challacombe Benedict T. Sherwood Benjamin T. Ristau Billy Lai Brechtje Nellensteijn Brielle Schreiter Carlo Trombetta Catherine Dowling Catherine Hobbs Cayo Augusto Estigarribia Benitez C. Lebâcle Cherrie Wing Yin Ho Chi‐Fai Ng Chloe Mount Chon Meng Lam Chris Blick C. T. A. Brown Christopher Gallegos

10.1016/j.euf.2022.06.001 article EN cc-by European Urology Focus 2022-06-25

To assess the contemporary malignancy rate in isolated de novo red patches bladder and associated risk factors for better selection of patch biopsy. Patients from IDENTIFY dataset; referred to secondary care with suspected urinary tract cancer found have on cystoscopy. We reported unadjusted prevalence that were biopsied; multivariable logistic regression was used explore cancer-associated including age, sex, smoking, type haematuria, LUTS, UTIs a suspicious-looking (as by cystoscopist)....

10.1002/bco2.475 article EN cc-by BJUI Compass 2025-01-01

Abstract Purpose Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent surgical treatment for benign prostatic hypertrophy. There currently lack data on peri-operative antibiotic prescribing patterns HoLEP and, thus, no consensus optimal practices. This study aims to assess practices HoLEP. Methods Members Endourological Society (EUS) were invited by e-mail complete REDCap survey. The survey inquired about surgeons’ practice setting, training, volume, and explored different...

10.1007/s00345-025-05535-2 article EN cc-by World Journal of Urology 2025-03-13

Background: Coronavirus disease 2019 (COVID-19) changed the practice of medicine in America. During March 2020 lockdown, elective cases were canceled to conserve hospital beds/resources resulting financial losses for health systems and delayed surgical care. Ambulatory percutaneous nephrolithotomy (aPCNL) has been shown be safe could a strategy ensure patients receive care that delayed, resources, maximize cost-effectiveness. We aimed compare safety cost-effectiveness undergoing aPCNL...

10.1089/end.2021.0482 article EN Journal of Endourology 2021-10-19

We aimed to compare holmium laser enucleation of the prostate (HoLEP) outcomes in patients with and without neurologic diseases (ND).

10.5489/cuaj.8683 article EN Canadian Urological Association Journal 2024-04-02

Background: Outcomes of holmium laser enucleation the prostate (HoLEP) for benign prostatic hyperplasia has been well studied. As comfort with procedure improved, number concurrent surgeries performed HoLEP increased. Technology and technique optimization have safely transitioned toward same-day catheter removal discharge. We aim to assess success safety transitioning a care pathway patients undergoing HoLEP. Materials Methods: With institutional review board approvals, we queried electronic...

10.1089/end.2021.0531 article EN Journal of Endourology 2021-12-01

Introduction: Intradetrusor onabotulinumtoxinA (OTA) injection is a well-established treatment option for refractory overactive bladder; however, its use at the time of holmium laser enucleation prostate (HoLEP) men with bladder outlet obstruction (BOO) and severe storage symptoms has not been previously reported. Materials Methods: We retrospectively identified BOO who underwent 200 U intradetrusor OTA (Botox®) HoLEP. Patients were propensity score matched to cohort HoLEP-only patients...

10.1089/end.2023.0074 article EN Journal of Endourology 2023-04-13

Introduction: Holmium laser enucleation of the prostate (HoLEP) has evidenced-based advantages in treating benign prostatic hyperplasia (BPH) relative to other interventions. Unfortunately, adoption HoLEP remained relatively low Medicare and National Surgical Quality Improvement Program populations. HoLEPs role as an inpatient surgical intervention is changing advancements technique systems have demonstrated feasibility same-day discharge. Thus, our objective was evaluate national trends...

10.1089/end.2023.0154 article EN Journal of Endourology 2023-07-28

Introduction: Holmium laser enucleation of the prostate (HoLEP) is routinely performed with a 24F, 26F, or 28F scope. Proponents larger scopes propose that bigger sheath size allows for superior flow and visibility leading to more efficient operation better hemostasis. Those utilizing smaller suggest less traumatic, resulting in lower stricture rates temporary incontinence. We sought compare outcomes ambulatory HoLEP using 24F Materials Methods: From May 2022 March 2023, we randomized...

10.1089/end.2023.0383 article EN Journal of Endourology 2023-10-03

The type VI secretion system of Pseudomonas aeruginosa has been shown to be responsible for the translocation bacteriolytic effectors into competing bacteria. A mechanistic understanding this widely distributed is developing and structural studies its components are ongoing. Two representative structures one highly conserved component, TssJ, from Escherichia coli Serratia marcescens have published. Here, X-­ray crystal structure TssJ1 P. presented at 1.4 Å resolution. overall among three...

10.1107/s1744309113012220 article EN Acta Crystallographica Section F Structural Biology and Crystallization Communications 2013-05-22

Introduction: Tranexamic acid (TXA) is a clot promoting agent utilized during orthopedic procedures to decrease bleeding. Urologists have demonstrated the benefits of TXA in percutaneous surgery. Our objective was assess safety and efficacy single-dose on same-day holmium laser enucleation prostate (HoLEP) outcomes. Methods: From September 2021 January 2022, we prospectively randomized 110 patients undergoing HoLEP either 1 g after induction or no treatment. Institutional Review Board (IRB)...

10.1089/end.2022.0407 article EN Journal of Endourology 2022-10-12

Holmium laser enucleation of the prostate (HoLEP) is a size-independent treatment option for benign prostatic hyperplasia. HoLEP has been shown to have excellent improvements in symptom scores and maximum flow rates that durable 2 decades. However, steep learning curve associated with prevented its widespread adoption. New advancements lasers, specifically Moses™ pulse-modulation technology, resulted hemostasis achieving same-day discharges catheter removals. We aimed perform cost-comparison...

10.1097/upj.0000000000000248 article EN Urology Practice 2021-09-20
Coming Soon ...